---
document_datetime: 2023-09-21 22:20:34
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ztalmy-epar-all-authorised-presentations_en.pdf
document_name: ztalmy-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9080698
conversion_datetime: 2025-12-20 13:59:25.534032
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                                                           |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------------------------------------------------------------------------------|
| EU/1/23/1743/001 | Ztalmy            | 50 mg/ml   | Oral suspension       | Oral use                  | bottle (HDPE)         | 110 ml                    | 1 bottle + 2 dosing syringes of 3 ml, 2 dosing syringes of 12 ml + 1 bottle adaptor |
| EU/1/23/1743/002 | Ztalmy            | 50 mg/ml   | Oral suspension       | Oral use                  | bottle (HDPE)         | 110 ml                    | 5 bottles + 5 dosing syringes of 12 ml + 5 bottle adaptors                          |